Skip to content

Noninterventional Observational Prospective Longitudinal Study of the Incidence of Ulcerative Colitis and Crohn's Disease Among the Adult Population of the Republic of Kazakhstan

Non-interventional Observational Prospective Longitudinal Study of the Incidence of Ulcerative Colitis and Crohn's Disease Among the Adult Population of the Republic of Kazakhstan

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05189327
Acronym
NUCaCD
Enrollment
2000
Registered
2022-01-12
Start date
2021-12-10
Completion date
2024-12-31
Last updated
2022-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn Disease Colon, Ulcerative Colitis Chronic

Keywords

Nonspecific Ulcerative colitis, Crohn Disease, Patient Registry

Brief summary

The NUCaCD study aims to develop a reliable registry of patients suffering inflammatory bowel diseases in the Republic of Kazakhstan.

Detailed description

The NUCaCD aims to study the prevalence of inflammatory bowel diseases in the Republic of Kazakhstan and create a reliable database, which will greatly facilitate future planning of the volume of health resources needed to address these diseases management and will help to optimize preventive measures and will support future research to better understand the etiology, new options treatment and factors affecting prognosis, relapses, development of complications and quality of life.

Interventions

OTHERNo intervention

Non-interventional study

Sponsors

FERRING Kazakhstan
CollaboratorUNKNOWN
Kazakhstan Scientific Society for Study of intestine diseases
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Availability of a signed informed consent form; or the presence of a disinterested witness if the patient is unable to examine and sign the consent form due to illiteracy or disability (for example, in the case of blindness); * The patient has a documented diagnosis of ulcerative colitis or Crohn's disease (endoscopy, histology, if indicated by radiation diagnostics); * Patients who have applied for treatment or are already taking treatment from a gastroenterologist / coloproctologist, including inpatients; * Citizenship of the Republic of Kazakhstan (or resides).

Exclusion criteria

* Patient takes part in an interventional clinical trial; * Patient is unable to follow the schedule of the visits; * Any condition that the PI believes would prevent a study participant from participating in the study.

Design outcomes

Primary

MeasureTime frameDescription
To study the incidence of NUC and CD in the Republic of Kazakhstan2 yearsTo study the incidence of NUC and CD in the Republic of Kazakhstan

Secondary

MeasureTime frameDescription
To study the patterns of the course of the disease and the treatment effect2 yearsTo study the patterns of the course of the disease and the effectiveness of drug therapy in outpatient and inpatient clinics.
Conduct an analysis of the completeness of the diagnosis and compliance with the national guidelines for the diagnosis and treatment of ulcerative colitis and Crohn's disease2 yearsConduct an analysis of the completeness of the diagnosis and compliance with the national guidelines for the diagnosis and treatment of ulcerative colitis and Crohn's disease
Analysis of the relationship between management strategies and treatment outcomes2 yearsAnalysis of the relationship between management strategies and treatment outcomes

Countries

Kazakhstan

Contacts

Primary ContactJamilya Kaibullayeva, PhD
kaibullaev@mail.ru+77471051195
Backup ContactKanat Khazhidinov, M.Sc.
k.khazhidinov@ksssid.com+77074138263

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026